Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic Malignancies

Clinical trial NCT03771222 · UNKNOWN

Trial details

NCT number: NCT03771222
Sponsor: Chinese PLA General Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Donor Lymphocyte Infusion Peripheral Blood Stem Cell Transplantation Relapse Graft-versus-host Disease Decitabine

Start date: 2019-01-01
Primary completion: 2020-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.